Gan & Lee Pharmaceuticals Co Ltd (603087) — Capital Reinvestment Ratio
Gan & Lee Pharmaceuticals Co Ltd (603087) has a Capital Reinvestment Ratio of 1.01x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥257.27 Million) in capital expenditures (CN¥260.89 Million). See 603087 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Gan & Lee Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Gan & Lee Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Check total reinvestment intensity of Gan & Lee Pharmaceuticals Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Gan & Lee Pharmaceuticals Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Gan & Lee Pharmaceuticals Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Gan & Lee Pharmaceuticals Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.18x | CN¥784.28 Million | CN¥926.09 Million | ▲ +43.9% |
| 2024 | 0.82x | CN¥537.31 Million | CN¥440.80 Million | ▼ -36.6% |
| 2023 | 1.29x | CN¥427.69 Million | CN¥553.06 Million | ▼ -61.0% |
| 2022 | 3.31x | CN¥296.68 Million | CN¥983.44 Million | ▲ +416.4% |
| 2021 | 0.64x | CN¥1.08 Billion | CN¥692.08 Million | ▲ +36.9% |
| 2020 | 0.47x | CN¥1.24 Billion | CN¥582.14 Million | ▲ +33.1% |
| 2019 | 0.35x | CN¥1.15 Billion | CN¥406.63 Million | ▼ -71.3% |
| 2018 | 1.23x | CN¥418.04 Million | CN¥513.44 Million | ▲ +170.6% |
| 2017 | 0.45x | CN¥949.60 Million | CN¥431.02 Million | ▲ +35.2% |
| 2016 | 0.34x | CN¥769.63 Million | CN¥258.48 Million | ▼ -59.2% |
| 2015 | 0.82x | CN¥447.42 Million | CN¥368.43 Million | ▼ -20.3% |
| 2014 | 1.03x | CN¥305.22 Million | CN¥315.47 Million | ▲ +111.5% |
| 2013 | 0.49x | CN¥204.73 Million | CN¥100.06 Million | — |